Preferred Label : Li-fraumeni syndrome;
Symbol : LFS;
CISMeF acronym : LFL; LFS;
Type : Phenotype, molecular basis known;
Alternative titles and symbols : Sarcoma family syndrome of LI and fraumeni; Sbla syndrome;
Included titles and symbols : Li-fraumeni-like syndrome; LFL;
Description : Li-Fraumeni syndrome (LFS) is a clinically and genetically heterogeneous inherited
cancer syndrome. LFS is characterized by autosomal dominant inheritance and early
onset of tumors, multiple tumors within an individual, and multiple affected family
members. In contrast to other inherited cancer syndromes, which are predominantly
characterized by site-specific cancers, LFS presents with a variety of tumor types.
The most common types are soft tissue sarcomas and osteosarcomas, breast cancer, brain
tumors, leukemia, and adrenocortical carcinoma. Classic LFS is defined as a proband
with a sarcoma before the age of 45 years and a first-degree relative with any cancer
before the age of 45 years and 1 additional first- or second-degree relative in the
same lineage with any cancer before the age of 45 years or a sarcoma at any age (Li
et al., 1988). Li-Fraumeni-like syndrome (LFL) is defined as a proband with any childhood
cancer, or a sarcoma, brain tumor, or adrenocortical tumor before the age of 45 years,
plus a first- or second-degree relative in the same lineage with a typical LFS tumor
at any age, and an additional first- or second-degree relative in the same lineage
with any cancer before the age of 60 years (Birch et al., 1994). A less restrictive
definition of LFL is 2 different LFS-related tumors in first- or second-degree relatives
at any age (Eeles, 1995). Approximately 70% of LFS cases and 40% of LFL cases contain
germline mutations in the p53 gene on chromosome 17p13.1 (Bachinski et al., 2005).
- Genetic Heterogeneity of Li-Fraumeni Syndrome A second form of Li-Fraumeni syndrome
(LFS2; 609265) is caused by mutation in the CHEK2 gene (604373), and an LFS locus
(LFS3; 609266) has been mapped to chromosome 1q23.;
Inheritance : Autosomal dominant;
Molecular basis : Caused by mutation in tumor protein p53 (TP53, 191170.0001);
Neoplasia : Breast cancer; Soft tissue sarcomas; Osteosarcomas; Brain tumors; Acute leukemias; Adrenocortical carcinomas; Lung adenocarcinoma; Colon cancer; Pancreatic cancer; Prostate cancer; Wilms tumor; Phyllodes tumor; Choriocarcinoma, gestational;
Prefixed ID : #151623;
Origin ID : 151623;
UMLS CUI : C0085390;
Automatic exact mappings (from CISMeF team)
Broader ORDO disease(s)
Currated CISMeF NLP mapping
DO Cross reference
Genes related to phenotype
HPO term(s)
ORDO concept(s)
Semantic type(s)
UMLS correspondences (same concept)
Validated automatic mappings to NTBT